Stock Events

Stock Events

ProUroCare Medical 

$0.000001
6
+$0.00+0%Monday 13:27

Statistics

Day High
0.0002
Day Low
0.0002
52W High
0.00505
52W Low
0.0001
Volume
26,169
Avg. Volume
553
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

Sep 30Expected
Q4 2011
Q1 2012
Q2 2012
Q3 2012
Q4 2012
Q1 2013
Q2 2013
-0.08
-0.06
-0.04
-0.02
Expected EPS
N/A
Actual EPS
-0.0221

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Baxter International
BAX
Mkt Cap11.9B
Baxter International Inc. offers a range of medical devices and services that compete in the broader healthcare and medical device sector, including urology.
Boston Scientific
BSX
Mkt Cap60.84B
Boston Scientific Corporation provides various medical solutions that compete in the urology space, including treatments for prostate conditions.
Medtronic
MDT
Mkt Cap123.49B
Medtronic plc offers medical technologies, services, and solutions, including those for urological conditions, competing in the medical device market.
Intuitive Surgical
ISRG
Mkt Cap152.62B
Intuitive Surgical, Inc. designs, manufactures, and markets robotic products for minimally invasive surgery, competing in the prostate surgery space.
Koninklijke Philips N.V.
PHG
Mkt Cap26.31B
Koninklijke Philips N.V. offers health technology, including diagnostic imaging and patient monitoring systems, competing in the broader healthcare technology market.
Stryker
SYK
Mkt Cap111.95B
Stryker Corporation specializes in medical technologies, including surgical equipment and robotics, which are used in various procedures including those related to urology.
Johnson & Johnson
JNJ
Mkt Cap657.68B
Johnson & Johnson provides healthcare products and services, including surgical systems and solutions for urological conditions, competing in the global healthcare market.
Danaher
DHR
Mkt Cap163.25B
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services, including diagnostic and treatment solutions for the healthcare sector.

About

ProUroCare Medical Inc. is dedicated to developing advanced products for the accurate identification and detailed assessment of male prostate diseases. The company's primary offering is the ProUroScan System, an innovative prostate imaging solution. This system empowers physicians to precisely document prostate irregularities that have been initially discovered through a digital rectal examination. ProUroCare has entered into strategic agreements with Artann Laboratories Inc., covering the licensing, ongoing development, and market commercialization of its ProUroScan System. The company was established in 1999 and is headquartered in Eden Prairie, Minnesota.
Show More
CEO
Benjamin Banks
Employees
2
Country
United States
ISIN
US74373C2061

Listings

OTC Link
US
PUMD

0 Comments

Share your thoughts

FAQs

What is ProUroCare Medical stock price today?▼
The current price of PUMD is $0.00 USD — it has increased by +0% in the past 24 hours. Watch ProUroCare Medical stock price performance more closely on the chart.
What is ProUroCare Medical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange ProUroCare Medical stocks are traded under the ticker PUMD.
What were ProUroCare Medical earnings last quarter?▼
PUMD earnings for the last quarter are -0.02 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
How many employees does ProUroCare Medical have?▼
As of November 2, 2026, the company has 2 employees.
In which sector is ProUroCare Medical located?▼
ProUroCare Medical operates in the Health & Wellness sector.
When did ProUroCare Medical complete a stock split?▼
ProUroCare Medical has not had any recent stock splits.
Where is ProUroCare Medical headquartered?▼
ProUroCare Medical is headquartered in Eden Prairie, United States.